Polaris Market Research reports that the global lab automation market was valued at USD 8.26 billion in 2025 and is projected to reach USD 14.68 billion by 2034, registering a CAGR of 6.6% during 2026–2034. The report examines market dynamics, segment performance, regional trends, and the competitive landscape.

Analyst Commentary on Lab Automation Market Growth

“Lab Automation is evolving as organizations respond to demand for high-throughput screening and faster laboratory workflows, the need to reduce manual errors and improve testing accuracy, and integration of robotics, AI, and data analytics. These developments are influencing technology adoption and investment priorities,” according to Polaris Market Research. “The report provides a detailed view of market sizing, segment trends, and regional forecasts for stakeholders assessing the sector.”

Lab Automation Market Statistics at a Glance

·         2025 Market Size: USD 8.26 billion

·         2026 Market Estimate: USD 8.91 billion

·         2034 Projected Size: USD 14.68 billion

·         CAGR (2026–2034): 6.6%

·         Largest Region (2025): North America, 41.3% share

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: Demand for high-throughput screening and faster laboratory workflows, the need to reduce manual errors and improve testing accuracy, and integration of robotics, ai, and data analytics.

Market Highlights: Subtotal automation accounted for 46.8% of revenue in 2025. Drug discovery represented 39.7%, reflecting the use of automated systems to improve the efficiency, accuracy, and throughput of screening and research processes.

Major Companies Covered: Abbott Laboratories; Agilent Technologies, Inc.; Aurora Biomed Inc.; Becton, Dickinson and Company; bioMérieux SA; Danaher Corporation; Eppendorf AG; F. Hoffmann-La Roche Ltd.; Hamilton Company; Hudson Robotics; PerkinElmer Inc.; QIAGEN N.V.; Siemens Healthineers AG; Tecan Group Ltd.; and Thermo Fisher Scientific Inc.

Segments Covered: product (automated workstation, off-the-shelf automated work cell, software, robotic system, and others); automation (task targeted, total laboratory, and subtotal automation); application (genomics solutions, microbiology, drug discovery, clinical diagnostics, and others); end use (hospitals and diagnostic laboratories, forensic laboratories, environmental testing laboratories, food and beverages, research and academic institutes, and biotechnology and pharma companies); and region.

Read More @ https://www.polarismarketresearch.com/industry-analysis/lab-automation-market

Recent Developments in the Lab Automation Market

May 2026: Tecan announced the launch of direct operations in India, establishing specialist laboratory automation service operations in the country.

Regional Snapshot

North America held the largest share at 41.3% in 2025, supported by established healthcare infrastructure, strong pharmaceutical and biotechnology industries, and R&D investment. Europe is projected to register a 7.1% CAGR through 2034, supported by investment in research, precision medicine, and advanced diagnostics.

Why It Matters for Buyers and Industry Stakeholders

For stakeholders evaluating lab automation market opportunities, the report benchmarks market size, company positioning, and segment-level forecasts. The analysis can support planning related to sourcing, technology selection, partnerships, and investment through 2034.

More Trending Latest Reports By Polaris Market Research:

fintech-market

catalyst-market

ashwagandha-extract-market

olive-oil-market

vitamin-k2-market

acrylonitrile-butadiene-styrene-abs-market

reverse-osmosis-membrane-market

supply-chain-management-market

predictive-disease-analytics-market